Human Bone Marrow Mesenchymal Stem Cells Induce Collagen Production and Tongue Cancer Invasion

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Salo, Sirpa ^a   Bitu, Carolina ^a   Merkku, Kalle ^a   Nyberg, Pia ^a   Bello, Ibrahim O ^b   Vuoristo, Jussi ^a   Sutinen, Meeri ^a   Vähänikkilä, Hannu ^a   Costea, Daniela E ^c   Kauppila, Joonas ^a   Lehenkari, Petri ^a   Dayan, Dan ^d   Vered, Marilena ^d,e   Risteli, Juha ^a   Salo, Tuula ^a,f,g,h  

^a UNIVERSITY OF OULU   (Finland)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF BERGEN   (Norway)

^d TEL AVIV UNIVERSITY   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

^f UNIVERSITY OF HELSINKI   (Finland)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h MEDICAL RESEARCH CENTER OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PROPEPTIDE; ANTINEOPLASTIC AGENT; COLLAGEN; COLLAGEN TYPE 1; CYTOKINE ANTIBODY; MESSENGER RNA; RANTES; RANTES ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER INHIBITION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CARCINOMA CELL; CELL INTERACTION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TONGUE CARCINOMA; TUMOR INVASION; UPREGULATION;

AGED; BONE MARROW CELLS; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CCL5; COLLAGEN; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NEOPLASM INVASIVENESS; TONGUE NEOPLASMS; TUMOR MICROENVIRONMENT; UP-REGULATION;

EID: 84886881080     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077692     Document Type: Article

References (54)

1. Allen M, Louise Jones J, (2011) Jekyll and hyde: The role of the microenvironment on the progression of cancer. J Pathol 223: 162-176. PubMed: 21125673.
2. Hogan NM, Dwyer RM, Joyce MR, Kerin MJ, (2012) Mesenchymal stem cells in the colorectal tumor microenvironment: Recent progress and implications. Int J Cancer 131: 1-7. doi:10.1002/ijc.27458. PubMed: 22290082.
3. Hanahan D, Coussens LM, (2012) Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 21: 309-322. doi:10.1016/j.ccr.2012.02.022. PubMed: 22439926.
4. Camacho DF, Pienta KJ, (2012) Disrupting the networks of cancer. Clin Cancer Res 18: 2801-2808. doi:10.1158/1078-0432.CCR-12-0366. PubMed: 22442061.
5. Lorusso G, Rüegg C, (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130: 1091-1103. doi:10.1007/s00418-008-0530-8. PubMed: 18987874.
6. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: The next generation. Cell 144: 646-674. doi:10.1016/j.cell.2011.02.013. PubMed: 21376230.
7. Vered M, Dayan D, Salo T, (2011) The role of the tumour microenvironment in the biology of head and neck cancer: Lessons from mobile tongue cancer. Nat Rev Cancer 11: 382; author reply: 21455256.
8. Vered M, Dobriyan A, Dayan D, Yahalom R, Talmi YP, et al. (2010) Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer. Cancer Sci 101: 274-280. doi:10.1111/j.1349-7006.2009.01357.x. PubMed: 19804423.
9. Bello IO, Vered M, Dayan D, Dobriyan A, Yahalom R, et al. (2011) Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 47: 33-38. doi:10.1016/j.oraloncology.2010.10.013. PubMed: 21112238.
10. Vered M, Dayan D, Yahalom R, Dobriyan A, Barshack I, et al. (2010) Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int J Cancer 127: 1356-1362. doi:10.1002/ijc.25358. PubMed: 20340130.
11. Dayan D, Salo T, Salo S, Nyberg P, Nurmenniemi S, et al. (2012) Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer. Cancer Med. 2: 128-140. PubMed: 23342263.
12. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, et al. (2008) Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339. doi:10.1158/0008-5472.CAN-08-0943. PubMed: 18519693.
13. Guo X, Oshima H, Kitmura T, Taketo MM, Oshima M, (2008) Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J Biol Chem 283: 19864-19871. doi:10.1074/jbc.M800798200. PubMed: 18495668.
14. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, et al. (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLOS ONE 4: e4992. doi:10.1371/journal.pone.0004992. PubMed: 19352430.
15. Koh BI, Kang Y, (2012) The pro-metastatic role of bone marrow-derived cells: A focus on MSCs and regulatory T cells. EMBO Rep 13: 412-422. doi:10.1038/embor.2012.41. PubMed: 22473297.
16. Fox JM, Chamberlain G, Ashton BA, Middleton J, (2007) Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137: 491-502. doi:10.1111/j.1365-2141.2007.06610.x. PubMed: 17539772.
17. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563. doi:10.1038/nature06188. PubMed: 17914389.
18. Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, et al. (2010) Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer 127: 2323-2333. doi:10.1002/ijc.25440. PubMed: 20473928.
19. Amé-Thomas P, Maby-El Hajjami H, Monvoisin C, Jean R, Monnier D, et al. (2007) Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: Role of stromal cells in follicular lymphoma pathogenesis. Blood 109: 693-702. doi:10.1182/blood-2006-05-020800. PubMed: 16985173.
20. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F 3rd, (2011) Concise review: Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29: 11-19. doi:10.1002/stem.559. PubMed: 21280155.
21. Waterman RS, Henkle SL, Betancourt AM, (2012) Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis. PLOS ONE 7: e45590. doi:10.1371/journal.pone.0045590. PubMed: 23029122.
22. Jensen BV, Johansen JS, Skovsgaard T, Brandt J, Teisner B, (2002) Extracellular matrix building marked by the N-terminal propeptide of protype I collagen reflect aggressiveness of recurrent breast cancer. Int J Cancer 98: 582-589. doi:10.1002/ijc.10187. PubMed: 11920619.
23. Marin L, Koivula MK, Jukkola-Vuorinen A, Leino A, Risteli J, (2011) Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases. Ann Clin Biochem 48: 447-451. doi:10.1258/acb.2011.011040. PubMed: 21733929.
24. Simojoki M, Santala M, Risteli J, Kauppila A, (2003) Discrepant expression of carboxy- and aminoterminal propeptides of type I procollagen predicts poor clinical outcome in epithelial ovarian cancer. Gynecol Oncol 88: 358-362. doi:10.1016/S0090-8258(02)00139-7. PubMed: 12648587.
25. Nurmenniemi S, Kuvaja P, Lehtonen S, Tiuraniemi S, Alahuhta I, et al. (2010) Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13. Exp Cell Res 316: 2676-2682. doi:10.1016/j.yexcr.2010.05.024. PubMed: 20553713.
26. Leskelä HV, Risteli J, Niskanen S, Koivunen J, Ivaska KK, et al. (2003) Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun 311: 1008-1013. doi:10.1016/j.bbrc.2003.10.095. PubMed: 14623282.
27. Kylmäniemi M, Oikarinen A, Oikarinen K, Salo T, (1996) Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal normal and malignant cells. J Dent Res 75: 919-926. doi:10.1177/00220345960750030901. PubMed: 8675803.
28. Kulasekara KK, Lukandu OM, Neppelberg E, Vintermyr OK, Johannessen AC, et al. (2009) Cancer progression is associated with increased expression of basement membrane proteins in three-dimensional in vitro models of human oral cancer. Arch Oral Biol 54: 924-931. doi:10.1016/j.archoralbio.2009.07.004. PubMed: 19674736.
29. Nurmenniemi S, Sinikumpu T, Alahuhta I, Salo S, Sutinen M, et al. (2009) A novel organotypic model mimics the tumor microenvironment. Am J Pathol 175: 1281-1291. doi:10.2353/ajpath.2009.081110. PubMed: 19679876.
30. Li C, Wong WH, (2001) Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc Natl Acad Sci U S A 98: 31-36. doi:10.1073/pnas.98.1.31. PubMed: 11134512.
31. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L, (1993) Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39: 635-640. PubMed: 8472358.
32. Chuang JY, Yang WH, Chen HT, Huang CY, Tan TW, et al. (2009) CCL5/CCR5 axis promotes the motility of human oral cancer cells. J Cell Physiol 220: 418-426. doi:10.1002/jcp.21783. PubMed: 19334035.
33. Cambien B, Richard-Fiardo P, Karimdjee BF, Martini V, Ferrua B, et al. (2011) CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRbeta in colorectal carcinoma. PLOS ONE 6: e28842. doi:10.1371/journal.pone.0028842. PubMed: 22205974.
34. Cheng WL, Wang CS, Huang YH, Tsai MM, Liang Y, et al. (2011) Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann Oncol 22: 2267-2276. doi:10.1093/annonc/mdq739. PubMed: 21343381.
35. Kuo PL, Shen KH, Hung SH, Hsu YL, (2012) CXCL1/GROalpha increases cell migration and invasion of prostate cancer by decreasing fibulin-1 expression through NF-kappaB/HDAC1 epigenetic regulation. Carcinogenesis 33: 2477-2487. doi:10.1093/carcin/bgs299. PubMed: 23027620.
36. Benelli R, Stigliani S, Minghelli S, Carlone S, Ferrari N, (2013) Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell. Prostate 73: 941-951. doi:10.1002/pros.22640. PubMed: 23334998.
37. Shintani S, Ishikawa T, Nonaka T, Li C, Nakashiro K, et al. (2004) Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer. Oncology 66: 316-322. doi:10.1159/000078333. PubMed: 15218300.
38. Raman D, Baugher PJ, Thu YM, Richmond A, (2007) Role of chemokines in tumor growth. Cancer Lett 256: 137-165. doi:10.1016/j.canlet.2007.05.013. PubMed: 17629396.
39. Velasco-Velázquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A, et al. (2012) CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Res 72: 3839-3850. doi:10.1158/1538-7445.AM2012-3839. PubMed: 22637726.
40. Wang SW, Wu HH, Liu SC, Wang PC, Ou WC, et al. (2012) CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLOS ONE 7: e35101. doi:10.1371/journal.pone.0035101. PubMed: 22506069.
41. Teppo S, Sundquist E, Vered M, Holappa H, Parkkisenniemi J, et al. (2013) The hypoxic tumor microenvironment regulates invasion of aggressive oral carcinoma cells. Exp Cell Res 319: 376-389. doi:10.1016/j.yexcr.2012.12.010. PubMed: 23262025.
42. Zhang Y, Yao F, Yao X, Yi C, Tan C, et al. (2009) Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol Rep 21: 1113-1121. PubMed: 19288016.
43. Parikka V, Väänänen A, Risteli J, Salo T, Sorsa T, et al. (2005) Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases. Matrix Biol 6: 438-447. PubMed: 16098718.
44. Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, et al. (2010) Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res 70: 5706-5716. doi:10.1158/1538-7445.AM10-5706. PubMed: 20570886.
45. Shen Y, Shen R, Ge L, Zhu Q, Li F, (2012) Fibrillar type I collagen matrices enhance metastasis/invasion of ovarian epithelial cancer via beta1 integrin and PTEN signals. Int J Gynecol Cancer 22: 1316-1324. doi:10.1097/IGC.0b013e318263ef34. PubMed: 23013730.
46. Nguyen-Ngoc KV, Cheung KJ, Brenot A, Shamir ER, Gray RS, et al. (2012) ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci U S A 109: E2595-E2604. doi:10.1073/pnas.1212834109. PubMed: 22923691.
47. Ye H, Yu T, Temam S, Ziober BL, Wang J, et al. (2008) Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 9: 69-2164-9-69. PubMed: 18254958.
48. Yamada S, Yanamoto S, Yoshida H, Yoshitomi I, Kawasaki G, et al. (2010) RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 39: 61-67. doi:10.1016/j.ijom.2009.10.003. PubMed: 19913389.
49. Zeisberg M, Neilson EG, (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437. doi:10.1172/JCI36183. PubMed: 19487819.
50. Pimenta Amaral TM, Da Silva Freire AR, Carvalho AL, Pinto CA, Kowalski LP, (2004) Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol 40: 780-786. doi:10.1016/j.oraloncology.2003.10.009. PubMed: 15288831.
51. Ohtani H, (1998) Stromal reaction in cancer tissue: Pathophysiologic significance of the expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions. Pathol Int 48: 1-9. doi:10.1111/j.1440-1827.1998.tb03979.x. PubMed: 9589457.
52. Rasmussen HB, Teisner B, Schrøder HD, Yde-Andersen E, Andersen JA, (1991) Fetal antigen 2 in primary and secondary brain tumors. Tumour Biol 12: 330-338. doi:10.1159/000217734. PubMed: 1798908.
53. Rasmussen HB, Teisner B, Andersen JA, Yde-Andersen E, Skjødt K, et al. (1992) Foetal antigen 2 (FA2) in the stromal reaction induced by breast carcinoma. APMIS 100: 39-47. doi:10.1111/j.1699-0463.1992.tb00837.x. PubMed: 1536719.
54. Tornehave D, Teisner B, Rasmussen HB, Chemnitz J, Kassem M, (1992) Fetal antigen 2 (FA2) in human fetal osteoblasts, cultured osteoblasts and osteogenic osteosarcoma cells. Anat Embryol (Berl) 186: 271-274. PubMed: 1416076.